SHI, Dexin. CRISPR-Cas9 for treatment of bipolar disorder caused by gene mutation. Highlights in Science, Engineering and Technology, [S. l.], v. 6, p. 60–65, 2022. DOI: 10.54097/hset.v6i.934. Disponível em: https://drpress.org/ojs/index.php/HSET/article/view/934. Acesso em: 9 may. 2026.